You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Clinical Strategies to Reduce Interferences in Laboratory Testing

  • Authors: Earle W. Holmes, Jr., PhD; James L. Januzzi, MD; Peter S. Pang, MD; Ali Tann, BSN, RN, CEN
  • CME / ABIM MOC / CE Released: 3/13/2017; Reviewed and Renewed: 4/18/2018
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/18/2019, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, ED physicians, primary care physicians, nurses and all clinicians interested in recognizing and reducing causes of lab error interference.

The goal of this activity is to increase awareness of causes of lab testing interference and strategies to prevent testing errors.

Upon completion of this activity, participants will have:

  1. Improved knowledge of the causes of laboratory testing interference
  2. Increased competence regarding the proper handling of lab specimens


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator(s)

  • Earle W. Holmes, PhD

    Professor of Pathology and Pharmacology; Director of Special Chemistry, Endocrinology, and Immunoserology; Loyola University Medical Center, Chicago, Illinois

    Disclosures

    Disclosure: Earle W. Holmes, PhD, has disclosed no relevant financial relationships.

    Dr Holmes does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Holmes does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Presenter(s)

  • James L. Januzzi, MD

    Hutter Family Professor of Medicine, Harvard Medical School; Division of Cardiology, Massachusetts General Hospital; Boston, Massachusetts

    Disclosures

    Disclosure: James L. Januzzi, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Roche
    Received grants for clinical research from: Roche

    Dr Januzzi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Januzzi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Peter S. Pang, MD

    Associate Professor of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana

    Disclosures

    Disclosure: Peter S. Pang, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals, Trevena, Inc.
    Received grants for clinical research from: Novartis Pharmaceuticals Corporation, Roche

    Dr Pang does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Pang does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Allison Tann, BSN, RN, CEN

    Indiana University Health, Methodist Hospital, Department of Emergency Medicine, Indianapolis, Indiana

    Disclosures

    Disclosure: Allison Tann, BSN, RN, CEN, has disclosed no relevant financial relationships.

    Ms Tann does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Ms Tann does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Joy P. Marko, MS, APN-C, CCMEP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Joy P. Marko, MS, APN-C, CCMEP, has disclosed no relevant financial relationships.

  • Ronald K. Miller, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Ronald K. Miller, PhD has disclosed no relevant financial

CME Reviewer/Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements


Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Clinical Strategies to Reduce Interferences in Laboratory Testing

Authors: Earle W. Holmes, Jr., PhD; James L. Januzzi, MD; Peter S. Pang, MD; Ali Tann, BSN, RN, CENFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 3/13/2017; Reviewed and Renewed: 4/18/2018

Valid for credit through: 4/18/2019, 11:59 PM EST

processing....

Editor’s Note: Since this activity was recorded, there has been a content update.The US Food and Drug Administration has given clearance to the fifth-generation Troponin T STAT assay. This is the first high-sensitivity troponin assay approved for use in the United States.

  • Print